Detalles de la búsqueda
1.
Anal dysplasia and anal cancer screening practices among liver transplant centers in the United States: Results of an online survey.
Transpl Infect Dis
; : e14286, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698665
2.
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).
Clin Infect Dis
; 77(8): 1102-1110, 2023 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338158
3.
The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practice.
Curr Opin Gastroenterol
; 36(5): 393-401, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32701604
4.
Further Considerations on the Natural History of Anal Dysplasia in Response to Jongen et al and Barroso.
J Infect Dis
; 224(7): 1270-1271, 2021 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33564877
5.
Response to Eriksson et al A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.
Transpl Infect Dis
; 23(2): e13493, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047468
6.
Cryptococcus neoformans infection in malignancy.
Mycoses
; 59(9): 542-52, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26932366
7.
Syphilitic hepatitis treated with doxycycline in an HIV-infected patient and review of the literature.
Sex Transm Dis
; 41(8): 507-10, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25013980
8.
Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities.
Open Forum Infect Dis
; 11(5): ofae220, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38770212
9.
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children.
Expert Rev Vaccines
; 23(1): 137-147, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111990
10.
An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants.
Expert Rev Vaccines
; 22(1): 906-917, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846456
11.
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Hum Vaccin Immunother
; 19(2): 2235238, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37529944
12.
A phase I study of intra-anal artesunate (suppositories) to treat anal high-grade squamous intraepithelial lesions.
PLoS One
; 18(12): e0295647, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100463
13.
Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies.
Pediatr Infect Dis J
; 42(11): 1021-1028, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566897
14.
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors.
Hum Vaccin Immunother
; 19(1): 2177066, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36864601
15.
Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560.
Microorganisms
; 10(10)2022 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36296263
16.
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Hum Vaccin Immunother
; 18(1): 1-14, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726574
17.
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE).
Vaccine
; 40(9): 1342-1351, 2022 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039194
18.
Predictors of in-hospital mortality in a cohort of people living with HIV (PLHIV) admitted to an academic medical intensive care unit from 2009 to 2014: A retrospective cohort study.
Medicine (Baltimore)
; 101(28): e29750, 2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839058
19.
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
Vaccine
; 40(1): 162-172, 2022 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34507861
20.
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV.
AIDS
; 36(3): 373-382, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750291